- Home
- TZUP vs SRZN Comparison
TZUP vs SRZN Comparison
Compare TZUP & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TZUP
- SRZN
- Stock Information
- Founded
- TZUP 2020
- SRZN 2015
- Country
- TZUP United States
- SRZN United States
- Employees
- TZUP N/A
- SRZN N/A
- Industry
- TZUP
- SRZN Medicinal Chemicals and Botanical Products
- Sector
- TZUP
- SRZN Health Care
- Exchange
- TZUP NYSE
- SRZN Nasdaq
- Market Cap
- TZUP 66.7M
- SRZN 72.8M
- IPO Year
- TZUP N/A
- SRZN N/A
- Fundamental
- Price
- TZUP $9.95
- SRZN $8.71
- Analyst Decision
- TZUP
- SRZN Strong Buy
- Analyst Count
- TZUP 0
- SRZN 2
- Target Price
- TZUP N/A
- SRZN $38.50
- AVG Volume (30 Days)
- TZUP 315.9K
- SRZN 22.6K
- Earning Date
- TZUP 08-11-2025
- SRZN 08-11-2025
- Dividend Yield
- TZUP N/A
- SRZN N/A
- EPS Growth
- TZUP N/A
- SRZN N/A
- EPS
- TZUP N/A
- SRZN N/A
- Revenue
- TZUP $487.00
- SRZN $11,638,000.00
- Revenue This Year
- TZUP N/A
- SRZN N/A
- Revenue Next Year
- TZUP N/A
- SRZN N/A
- P/E Ratio
- TZUP N/A
- SRZN N/A
- Revenue Growth
- TZUP N/A
- SRZN N/A
- 52 Week Low
- TZUP $2.02
- SRZN $5.90
- 52 Week High
- TZUP $13.44
- SRZN $18.17
- Technical
- Relative Strength Index (RSI)
- TZUP N/A
- SRZN 47.45
- Support Level
- TZUP N/A
- SRZN $8.00
- Resistance Level
- TZUP N/A
- SRZN $8.94
- Average True Range (ATR)
- TZUP 0.00
- SRZN 0.72
- MACD
- TZUP 0.00
- SRZN -0.07
- Stochastic Oscillator
- TZUP 0.00
- SRZN 27.14
About TZUP THUMZUP MEDIA CORP
Thumzup Media Corp operates in the social media branding and marketing industry. The company operates in a single business segment which is social media marketing. The Thumzup App works on both iPhone and Android mobile operating systems and connects brands and people who use and love these brands. The easy-to-use dashboard allows advertisers to programmatically customize their campaigns. Cash payments are made to App users/creators through Venmo and PayPal.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).